Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Prescription Drug Monitoring Program
Regulatory
DEA delays OUD, VA telehealth Rx rules until December
The two telehealth prescribing rules—which were supposed to go into effect today—have been delayed until December 31.
Emma Beavins
Mar 21, 2025 10:30am
Appriss Health buys PatientPing for reported $500M
Mar 24, 2021 7:35am
Industry Voices—Healthcare must double down on drug diversion
Aug 24, 2020 12:01am
AMA report: Nearly 40% decline on opioid prescriptions
Jul 21, 2020 11:56am
Industry Voices—Technology makes headway in opioid crisis
Oct 28, 2019 12:01am
Appriss Health acquires behavioral health platform OpenBeds
Oct 2, 2019 8:00am
